Computational POM and DFT Evaluation of Experimental in-vitro cancer inhibition of staurosporine-ruthenium(II) complexes: the power force of organometallics in drug design
Computational POM and DFT Evaluation of Experimental in-vitro cancer inhibition of staurosporine-ruthenium(II) complexes: the power force of organometallics in drug design